New Methods To Assess Susceptibilities of Aspergillus Isolates to Caspofungin
Open accessAbstract
Echinocandins are a group of antifungal agents that target 1,3-β-glucan synthase, causing disruption of mold growth at cells compromising tips and branch points. In part because echinocandins do not induce clear growth inhibition end points using broth dilution techniques, methods to test susceptibility have not yet been standardized. We developed a novel susceptibility assay that measures growth of Aspergillus species on solid agar media that contain serial dilutions of caspofungin (agar dilution). Results of agar dilution testing of multiple isolates were compared to results obtained by broth microdilution (MIC), microscopic evaluation (minimal effective concentration [MEC]), and a new method to measure fungal burden, quantification of secreted hyphal antigen. MICs obtained by the agar dilution method were within 1 dilution of MECs for 85% of the Aspergillus isolates; the highest agreement was observed for isolates of Aspergillus niger (95%), which were particularly susceptible to caspofungin. Agar dilution MICs were also consistent with those obtained by quantifying antigen secretion. MICs obtained by broth microdilution were different than MICs by any other method. Several Aspergillus isolates with decreased susceptibility to caspofungin were identified. Agar dilution is simple and reproducible, and results were consistent with the results of more technically demanding techniques. This method may be appropriate for use in the clinical laboratory.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Agar dilution has been used for antifungal agent-drug combinations against Candida sp., Aspergillus, Fusarium and dermatophytes.
“It has been also used for antifungal agent-drugs combinations against Candida sp., Aspergillus, Fusarium and dermatophytes [80], [81], [82], [83].”
From Methods for in vitro evaluating antimicrobial activity: A review (2016) · cites this paper as [81]
Cited by
Sorted by citations
Methods for in vitro evaluating antimicrobial activity: A review
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2015.11.005 · Cited by 7,264 · see citing works
Fungal echinocandin resistance
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267 · see citing works
Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes
Bajaj, K., Buchanan, R. M., & Grapperhaus, C. A. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111620 · Cited by 122 · see citing works
- Authors
- Imhof, A., Balajee, S. A., & Marr, K. A.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Marr, Kieren A.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2003-12
- Volume
- 41
- Issue
- 12
- Pages
- 5683-5688
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC309030
- OpenAlex
- W2146611080
- Cited by
- 48
- References
- 0
- Citations by year
- 2026: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 2 · 2012: 1
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (102316)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (102316)
- National Institutes of Health (5k08ai001571-02)
- National Institute of Allergy and Infectious Diseases (K08-AI01571, R21AI055928)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
- Keywords
- caspofungin, echinocandins, Aspergillus, antifungal susceptibility testing, beta-1,3-glucan synthase, minimum inhibitory concentration, Aspergillus niger, reduced susceptibility
- MeSH terms
- Caspofungin, Agar, Antifungal Agents, Aspergillus, Aspergillus flavus, Aspergillus fumigatus, Candida albicans, Humans, Indicators and Reagents, Microbial Sensitivity Tests, Peptides, Peptides, Cyclic, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review